Amarillo Biosciences to Be Featured Live on Market News First on May 30

AMARILLO, TX -- (MARKET WIRE) -- May 29, 2007 -- Amarillo Biosciences, Inc. (ABI) (OTCBB: AMAR) today announced that Dr. Joseph Cummins, President & CEO, will be featured on Market News First (www.mn1.com). The exclusive interview with the MN1 news team is scheduled for 1:00 PM EDT on May 30. Dr. Cummins will be previewing information to be presented at the Annual Shareholders' Meeting, Friday, June 1 at 7:00 PM at the Ambassador Hotel, 3100 I-40 West, Amarillo, Texas. Dr. Cummins will be discussing human Phase 2 clinical trials in Behcet's disease, oral warts and hepatitis C. The study on 90 patients with Behcet's disease is being conducted in Turkey. The study of oral warts in 80 HIV+ patients is being conducted at 10 clinical sites in the USA. The study on 152 hepatitis C patients is being conducted in Taiwan. In addition, Dr. Cummins will discuss ongoing research in influenza.